Natalie Raffoul
Overview
Explore the profile of Natalie Raffoul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen M, Brown S, Banks E, Woodward M, Zhang Y, Raffoul N, et al.
Aust J Gen Pract
. 2024 Dec;
53(12 Suppl):S20-S24.
PMID: 39693745
Background: A new Australian guideline for cardiovascular disease (CVD) risk assessment and management was published in 2023, including new risk treatment thresholds. Objective: This article summarises the published peer-reviewed global...
2.
Schutte A, Bennett B, Chow C, Cloud G, Doyle K, Girdis Z, et al.
Med J Aust
. 2024 Jul;
221(3):126-134.
PMID: 38990122
No abstract available.
3.
Jennings G, Raffoul N, Nelson M, Australian Guideline For Assessing And Managing Cardiovascular Disease Risk E
Aust Prescr
. 2024 May;
47(2):57-63.
PMID: 38737366
The outdated cardiovascular disease risk calculator has been reported to overestimate cardiovascular disease risk for a contemporary Australian population, and does not include relevant variables, such as socioeconomic disadvantage, which...
4.
Nelson M, Banks E, Brown A, Chow C, Peiris D, Stocks N, et al.
Med J Aust
. 2024 Apr;
220(9):482-490.
PMID: 38623719
Introduction: The 2023 Australian guideline for assessing and managing cardiovascular disease risk provides updated evidence-based recommendations for the clinical assessment and management of cardiovascular disease (CVD) risk for primary prevention....
5.
Fajardo M, Batcup C, Ayre J, McKinn S, Knight J, Raffoul N, et al.
Patient Educ Couns
. 2024 Feb;
123:108192.
PMID: 38377707
Objective: To explore the effect of SMS nudge messages amongst people with varying health literacy on their intention to get a Heart Health Check. Methods: A 3 (Initial SMS: scarcity,...
6.
Redfern J, Shang C, Hsu M, Doyle K, Nutbeam D, Audehm R, et al.
Heart Lung Circ
. 2023 Sep;
32(10):1141-1147.
PMID: 37758637
The Australian Cardiovascular Alliance (ACvA), the Cardiac Society of Australia and New Zealand (CSANZ) and the National Heart Foundation of Australia (NHFA) recently joined forces to bring the cardiovascular and...
7.
Brown S, Banks E, Woodward M, Raffoul N, Jennings G, Paige E
Med J Aust
. 2023 Jul;
219(4):173-186.
PMID: 37496296
This article reviews the risk equations recommended for use in international cardiovascular disease (CVD) primary prevention guidelines and assesses their suitability for use in Australia against a set of a...
8.
Raffoul N, Brims K, Zeng J, Knight J, Asham A, Mitchell J, et al.
Aust J Gen Pract
. 2023 Jul;
52(7):481-489.
PMID: 37423246
Background And Objectives: The uptake of formal cardiovascular disease risk assessment in the primary prevention setting is low. We tested the feasibility of an SMS recall system to invite eligible...
9.
Zwack C, Smith C, Poulsen V, Raffoul N, Redfern J
Int J Environ Res Public Health
. 2023 Feb;
20(3).
PMID: 36767091
A critical aspect of coronary heart disease (CHD) care and secondary prevention is ensuring patients have access to evidence-based information. The purpose of this review is to summarise the guiding...
10.
Ward N, Watts G, Bishop W, Colquhoun D, Hamilton-Craig C, Hare D, et al.
Heart Lung Circ
. 2023 Jan;
32(3):287-296.
PMID: 36707360
This position statement provides guidance to cardiologists and related specialists on the management of adult patients with elevated lipoprotein(a) [Lp(a)]. Elevated Lp(a) is an independent and causal risk factor for...